Literature DB >> 17339458

Stimulation of an unfolded protein response impairs MHC class I expression.

Sérgio F de Almeida1, John V Fleming, Jorge E Azevedo, Maria Carmo-Fonseca, Maria de Sousa.   

Abstract

HFE C282Y is an example of a mutant protein that does not fold correctly, is retained in the endoplasmic reticulum, and was found previously to diminish surface expression of MHC class I (MHC-I). We now show that its expression in 293T cells triggers an unfolded protein response (UPR), as revealed by the increased levels of H chain binding protein, GRP94, and C/EBP homologous protein. Elevated levels of these proteins were also found in HFE C282Y homozygous PBMCs. Following the UPR induction, a decrease in MHC-I cell surface expression was observed. This defect in MHC-I could be mimicked, however, by overexpression of transcriptionally active isoforms of activating transcription factor-6 and X box-binding protein-1, which induced the UPR, and reversed in HFE C282Y-expressing cells by using dominant-negative constructs that block UPR signaling. The present results provide evidence to the finding that stimulation of an UPR affects MHC-I expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339458     DOI: 10.4049/jimmunol.178.6.3612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.

Authors:  Rafal Bartoszewski; Joseph W Brewer; Andras Rab; David K Crossman; Sylwia Bartoszewska; Niren Kapoor; Cathy Fuller; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

2.  Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.

Authors:  Yiting Liu; Sang Y Lee; Elizabeth Neely; Wint Nandar; Mthabisi Moyo; Zachary Simmons; James R Connor
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

Review 3.  The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells.

Authors:  M Zanetti; J J Rodvold; N R Mahadevan
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

4.  Endoplasmic reticulum stress and atherosclerosis.

Authors:  Gökhan S Hotamisligil
Journal:  Nat Med       Date:  2010-04       Impact factor: 53.440

5.  Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.

Authors:  Paul J Schmidt; Nancy C Andrews; Mark D Fleming
Journal:  Blood       Date:  2010-09-13       Impact factor: 22.113

6.  Function of the hemochromatosis protein HFE: Lessons from animal models.

Authors:  Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

7.  Abnormal expression of collagen IV in lens activates unfolded protein response resulting in cataract.

Authors:  Zeynep Firtina; Brian P Danysh; Xiaoyang Bai; Douglas B Gould; Takehiro Kobayashi; Melinda K Duncan
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 8.  Micro(RNA)managing endoplasmic reticulum stress.

Authors:  Andrew E Byrd; Joseph W Brewer
Journal:  IUBMB Life       Date:  2013-04-03       Impact factor: 3.885

9.  Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases.

Authors:  Arnaud Pommier; Naishitha Anaparthy; Nicoletta Memos; Z Larkin Kelley; Alizée Gouronnec; Ran Yan; Cédric Auffray; Jean Albrengues; Mikala Egeblad; Christine A Iacobuzio-Donahue; Scott K Lyons; Douglas T Fearon
Journal:  Science       Date:  2018-05-17       Impact factor: 47.728

10.  ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity.

Authors:  Susana J Oliveira; Jorge P Pinto; Gonçalo Picarote; Vera M Costa; Félix Carvalho; Maria Rangel; Maria de Sousa; Sérgio F de Almeida
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.